Bayer AG News Headlines

BAYRY 
$137.68
*  
0.52
0.38%
Get BAYRY Alerts
*Delayed - data as of Sep. 17, 2014 11:26 ET  -  Find a broker to begin trading BAYRY now


Community Rating:
View:    BAYRY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Bayer, Orion Begin Phase III Study Of Novel Prostate Cancer Agent ODM-201
9/16/2014 2:55:00 AM - RTT News

Sanofi Reports Data on Multiple Sclerosis Drug Lemtrada - Analyst Blog
9/12/2014 5:30:00 PM - Zacks.com

Bayer Presents Positive Long-Term Results on Adempas - Analyst Blog
9/9/2014 4:25:00 PM - Zacks.com

A Look At German Pharma And Chemicals Company Bayer AG
9/9/2014 4:23:00 AM - Seeking Alpha

OncoMed's Shares Gain on Lifting of Partial Clinical Hold - Analyst Blog
9/8/2014 6:00:00 PM - Zacks.com

Bayer/Regeneron Looking for Eylea Label Expansion in Japan - Analyst Blog
9/8/2014 4:45:00 PM - Zacks.com

The Surprising Over-the-Counter Pain Reliever Consumers Are Least Loyal To
9/6/2014 9:23:02 AM - Motley Fool

Regeneron: Bayer's Japan Unit Submits Application For EYLEA Injection In Japan
9/4/2014 3:11:00 AM - RTT News

Bayer Discloses Encouraging Data on Anticoagulant Xarelto - Analyst Blog
9/3/2014 5:10:00 PM - Zacks.com

Bayer/Johnson & Johnson to Expand Xarelto Label Further - Analyst Blog
9/2/2014 6:30:00 PM - Zacks.com

Bayer HealthCare Announces Results From X-VeRT Study On Xarelto - Quick Facts
9/2/2014 2:33:00 AM - RTT News

OncoMed's Vantictumab Studies' Partial Clinical Hold Lifted - Analyst Blog
8/29/2014 5:50:00 PM - Zacks.com

Health Care Down as Traders Bet on Growth Areas -- Health-Care Roundup
8/29/2014 4:52:00 PM - Dow Jones Business News

J&J, Bayer Aim to Expand Xarelto's Uses
8/29/2014 10:55:00 AM - Dow Jones Business News

Return To Behemoth Stocks
8/27/2014 10:25:00 AM - Seeking Alpha

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
8/26/2014 3:31:00 PM - Investopedia

Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
8/22/2014 5:55:00 PM - Zacks.com

EUROPE MARKETS: Maersk Lifts Stoxx 600 With 4.9% Leap
8/19/2014 12:01:00 PM - Dow Jones Business News

Boston Scientific Poised on Core Market Stabilization - Analyst Blog
8/14/2014 2:50:00 PM - Zacks.com

Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
8/12/2014 5:20:00 PM - Zacks.com

Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
8/5/2014 3:02:00 PM - Zacks.com

EUROPE MARKETS: Germany's DAX Posts Biggest Weekly Loss In Two Years
8/1/2014 11:53:00 AM - Dow Jones Business News

Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog
7/31/2014 10:41:00 AM - Zacks.com

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
7/30/2014 7:00:00 PM - Zacks.com

Bayer Q2 Profit Rises 13%
7/30/2014 4:07:00 AM - RTT News